Combination of ponatinib and blinatumomab in Philadelphia chromosome-positive acute lymphoblastic leukemia: Early results from a phase II study.

被引：23

作者：

Short, Nicholas James

Kantarjian, Hagop M.

Konopleva, Marina

Jain, Nitin

Huang, Xuelin

Ravandi, Farhad

Wierda, William G.

Borthakur, Gautam

Sasaki, Koji

Issa, Ghayas C.

Alvarado, Yesid

Pemmaraju, Naveen

Garcia-Manero, Guillermo

Thankachan, Jennifer

Garris, Rebecca

Jabbour, Elias

机构：

[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA

[3] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA

来源：

关键词：

D O I：

10.1200/JCO.2021.39.15_suppl.7001

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

7001

引用

页数：3